Funding Rounds
BioLamina

BioLamina Series A (2023, $18M)

BioLamina

Cell therapy development paltform.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Series A

Raised Amount: $18.21M

Raised Date: 2023-12-01

Investors